Joerg Moelleken
22Patents
3h-index
74Co-inventors
62Inventor score
Filing activity: Feb 22, 2012 → Nov 14, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9714292B2 | Bispecific antibodies against human TWEAK and human IL17 and uses thereof | Chemistry; Metallurgy | 21 | Active |
| US9926379B2 | Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5 | Chemistry; Metallurgy | 10 | Active |
| US9309319B2 | Antibodies against human IL33R and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US10730938B2 | Bispecific antibodies and methods of use in ophthalmology | Chemistry; Metallurgy | 3 | Active |
| US10822402B2 | Humanized anti-tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US9862763B2 | Humanized anti-tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10087246B2 | Anti-PDGF-B antibodies and methods of use | Chemistry; Metallurgy | 2 | Active |
| US11214622B2 | Antibodies specific for DR5 and methods of use | Chemistry; Metallurgy | 2 | Active |
| US10538585B2 | Anti-ANG2 antibodies and methods of use | Chemistry; Metallurgy | 2 | Active |
| US11958912B2 | Method for determining the in vivo interaction mode | Physics | 1 | Active |
| US12297263B2 | Humanized anti-Tau(PS422) antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11739142B2 | Bispecific anti-CCL2 antibodies | Chemistry; Metallurgy | 0 | Active |
| US12157770B2 | Anti-HLA-G antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12103967B2 | Bispecific anti-CCL2 antibodies | Chemistry; Metallurgy | 0 | Active |
| US8785153B2 | Antibodies against human IL33R and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11572404B2 | Humanized anti-Tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11732036B2 | Antibody that binds to VEGF-A and ANG2 and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10329346B2 | TNFa-IL-17 bispecific antibodies | Chemistry; Metallurgy | 0 | Active |
| US12287335B2 | Direct affinity measurement of human IgG1 binding multimeric antigens | Physics | 0 | Active |
| US11820816B2 | Anti-VEGF antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11130804B2 | Antibody that binds to VEGF and IL-1beta and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11866490B2 | Antibody that binds to VEGF and IL-1beta and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.